##  [Novartis announces FDA filing acceptance of Xolair® (omalizumab) prefilled syringe for self-administration across all indications](/us-en/news/media-releases/novartis-announces-fda-filing-acceptance-xolair-omalizumab-prefilled-syringe-self-administration-across-all-indications-0 "Novartis announces FDA filing acceptance of Xolair® (omalizumab) prefilled syringe for self-administration across all indications") 

  Aug 13, 2020